Relationship of gelatinases-tight junction proteins and blood-brain barrier permeability in the early stage of cerebral ischemia and reperfusion

Neural Regeneration Research

Volumn 7, Issue 31, 2012, Pages 2405-2412

  Xin, Haolin ^a   Liang, Wenzhao ^a   Mang, Jing ^a   Lin, Lina ^b   Guo, Na ^a   Zhang, Feng ^b   Xu, Zhongxin ^a  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Blood brain barrier; Claudin 5; Evans blue; Gelatinases; GM6001; Junction protein; Matrix metalloproteinase; Middle cerebral artery occlusion; Neural regeneration; Occludin; Permeability; Reperfusion injury

Indexed keywords

EID: 84925969910     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2012.31.001     Document Type: Article

References (32)

1. [1] Feske SK. Thrombolytic therapy of acute stroke. Circulation. 2012;125(21):2662-2666.
2. [2] Derex L, Nighoghossian N. Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update. J Neurol Neurosurg Psychiatry. 2008;79(10):1093-1099.
3. [3] Bednarczyk J, Lukasiuk K. Tight junctions in neurological diseases. Acta Neurobiol Exp (Wars). 2011;71(4): 393-408.
4. [4] Chen F, Ohashi N, Li W, et al. Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure. Hepatology. 2009;50(6): 1914-1923.
5. [5] Feng S, Cen J, Huang Y, et al. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. PLoS One. 2011;6(8):e20599.
6. [6] Hawkins BT, Lundeen TF, Norwood KM, et al. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia. 2007;50(1):202-211.
7. [7] Beauchesne E, Desjardins P, Hazell AS, et al. Altered expression of tight junction proteins and matrix metalloproteinases in thiamine-deficientmouse brain. Neurochem Int. 2009;55(5):275-281.
8. [8] Chen W, Hartman R, Ayer R, et al. Matrix metalloproteinases inhibition provides neuroprotection against hypoxia-ischemia in the developing brain. J Neurochem. 2009;111(3):726-736.
9. [9] McColl BW, Rothwell NJ, Allan SM. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J Neurosci. 2008;28(38):9451-9462.
10. [10] Bauer AT, Bürgers HF, Rabie T, et al. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab. 2010;30(4):837-848.
11. [11] Liu W, Hendren J, Qin XJ, et al. Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia. J Neurochem. 2009;108(3):811-820.
12. [12] Lischper M, Beuck S, Thanabalasundaram G, et al. Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions. Brain Res. 2010;1326:114-127.
13. [13] Mishiro K, Ishiguro M, Suzuki Y, et al. A broad-spectrum matrix metalloproteinase inhibitor prevents hemorrhagic complications induced by tissue plasminogen activator in mice. Neuroscience. 2012;205:39-48.
14. [14] Liu W, Chen Q, Liu J, et al. Normobaric hyperoxia protects the blood brain barrier through inhibiting Nox2 containing NADPH oxidase in ischemic stroke. Med Gas Res. 2011; 1(1):22.
15. [15] Sood RR, Taheri S, Candelario-Jalil E, et al. Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain. J Cereb Blood Flow Metab. 2008;28(2):431-438.
16. [16] Amantea D, Russo R, Gliozzi M, et al. Early upregulation of matrix metalloproteinases following reperfusion triggers neuroinflammatory mediators in brain ischemia in rat. Int Rev Neurobiol. 2007;82:149-169.
17. [17] Zehendner CM, Librizzi L, de Curtis M, et al. Caspase-3 contributes to ZO-1 and Cl-5 tight-junction disruption in rapid anoxic neurovascular unit damage. PLoS One. 2011;6(2):e16760.
18. [18] Marco S, Skaper SD. Amyloid beta-peptide1-42 alters tight junction protein distribution and expression in brain microvessel endothelial cells. Neurosci Lett. 2006;401(3): 219-224.
19. [19] Andras IE, Pu H, Deli MA, et al. HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. J Neurosci Res. 2003; 74(2):255-265.
20. [20] Song L, Ge S, Pachter JS. Caveolin-1 regulates expression of junction associated proteins in brain microvascular endothelial cells. Blood. 2007;109(4): 1515-1523.
21. [21] Kondo N, Ogawa M, Wada H, et al. Thrombin induces rapid disassembly of claudin-5 from the tight junction of endothelial cells. Exp Cell Res. 2009;315(17):2879-2887.
22. [22] Nagaraja TN, Ewing JR, Karki K, et al. MRI and quantitative autoradiographic studies following bolus injections of unlabeled and (14)C-labeled gadolinium-diethylenetriaminepentaacetic acid in a rat model of stroke yield similar distribution volumes and blood-to-brain influx rate constants. NMR Biomed. 2011;24(5):547-558.
23. [23] Jiao H, Wang Z, Liu Y, et al. Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult. J Mol Neurosci. 2011;44(2):130-139.
24. [24] Penes MC, Li X, Nagy JI. Expression of zonula occludens-1 (ZO-1) and the transcription factor ZO-1-associated nucleic acidbinding protein (ZONAB)-MsY3 in glial cells and colocalization at oligodendrocyte and astrocyte gap junctions in mouse brain. Eur J Neurosci. 2005;22(2):404-418.
25. [25] Piontek J, Winkler L, Wolburg H, et al. Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J. 2008;22(1):146-158.
26. [26] Wong V, Am J. Phosphorylation of occludin correlates with occludin localization and function at the tight junction. Am J Physiol. 1997;273(6 Pt 1):C1859-1867.
27. [27] Bojarski C, Weiske J, Schöneberg T, et al. The specific fates of tight junction proteins in apoptotic epithelial cells. J Cell Sci. 2004;117(Pt 10):2097-2107.
28. [28] Sandoval KE, Witt KA. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis. 2008; 32(2):200-219.
29. The Ministry of Science and Technology of the People’s Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.
30. [30] Laing RJ, Jakubowski J, Laing RW. Middle cerebral artery occlusion without craniectomy in rats. Which method works best? Stroke. 1993;24(2):294-297.
31. [31] Zierath D, Hadwin J, Savos A, et al. Anamnestic recall of stroke-related deficits: an animal model. Stroke. 2010; 41(11):2653-2660.
32. [32] Belayev L, Busto R, Zhao W, et al. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res. 1996;739(1-2): 88-96.